Statistics for Benitec Biopharma (id:6282 BNTC)

Valuation metrics

Market cap

211.62M

Enterprise value

62.15M

Trailing P/E (ttm)

Forward P/E

-1.13

PEG ratio

-1.13

Price/Sales (ttm)

Price/Book (mrq)

2.28

Enterprise Value/Revenue

Enterprise Value/EBITDA

-2.77

Overview

Shares outstanding

19.82M

Float

3.88M

Shares short

56.89K

% Held by insiders

0.04%

% Held by institutions

0.83%

Average volume (10 days)

36.56K

Average volume (90 days)

Price summary

52-Week low

2.69

52-Week high

12.89

52-Week change

69.50%

Beta

0.88

50-Day moving average

9.91

200-Day moving average

7.79

Dividends and splits

Forward annual dividend rate

0.01

Forward annual dividend yield

0.00

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

November 18th, 2019

Ex-dividend date

June 01th, 2018

Last split factor

2:1

Last split date

July 26th, 2023

Financials

Fiscal year

Fiscal year ends

June 30th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-49.60%

Return on equity

-91.68%

Income statement

Revenue (ttm)

Revenue per share (ttm)

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-22,403,000.00

Net income to common (ttm)

-22,370,000.00

Diluted EPS (ttm)

-5.51

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

50.87M

Total cash per share (mrq)

4.82

Total debt (mrq)

284.00K

Total Debt/Equity (mrq)

0.60

Current ratio (mrq)

1.05K%

Book value per share (mrq)

4.68

Cash flow

Cash flow statement

-19,403,000.00

Levered free cash flow (LFCF)

-11,681,250.00